These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1080042)

  • 1. Centrally-mediated cardiovascular effects of 5-hydroxytryptophan in MAO-inhibited dogs: modification by autonomic antagonists.
    Antonaccio MJ; Robson RD
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):200-10. PubMed ID: 1080042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
    Antonaccio MJ; Robson RD
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):89-102. PubMed ID: 4281293
    [No Abstract]   [Full Text] [Related]  

  • 3. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ; Kerwin L
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition.
    Warsh JJ; Stancer HC
    J Pharmacol Exp Ther; 1976 Jun; 197(3):545-55. PubMed ID: 1084420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of serotonergic agents on the body temperature.
    Pawlowski L
    Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation of enhanced reflex vagal bradycardia by L-dopa via central dopamine formation in dogs.
    Antonaccio MJ; Kerwin L
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):56-68. PubMed ID: 869641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally mediated hypotension and bradycardia by methysergide in anesthetized dogs.
    Antonaccio MJ; Kelly E; Halley J
    Eur J Pharmacol; 1975 Aug; 33(1):107-17. PubMed ID: 1175677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of Casimiroa edulis; II. Cardiovascular effects in the anesthesized dog.
    Vidrio H; Magos GA
    Planta Med; 1991 Jun; 57(3):217-20. PubMed ID: 1896518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.
    Ortmann R; Waldmeier PC; Radeke E; Felner A; Delini-Stula A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):185-92. PubMed ID: 6966764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central depression of carotid baroreceptor pressor response, arterial pressure and heart rate by 5-hydroxytryptophan: influence of supracollicular areas of the brain.
    Tadepalli AS; Mills E; Schanberg SM
    J Pharmacol Exp Ther; 1977 Aug; 202(2):310-9. PubMed ID: 301930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
    Woodman OL; Vatner SF
    J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular responses to amitraz in the presence of autonomic antagonists and agonists.
    Cullen LK; Reynoldson JA
    Arch Int Pharmacodyn Ther; 1988; 296():45-56. PubMed ID: 3240021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.